Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Macrogenics (MGNX) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Macrogenics (MGNX) over the last 14 years, with Q3 2025 value amounting to $63.2 million.

  • Macrogenics' Shares Outstanding (Weighted Average) rose 77.98% to $63.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $63.2 million, marking a year-over-year increase of 77.98%. This contributed to the annual value of $62.6 million for FY2024, which is 111.74% up from last year.
  • Latest data reveals that Macrogenics reported Shares Outstanding (Weighted Average) of $63.2 million as of Q3 2025, which was up 77.98% from $63.1 million recorded in Q2 2025.
  • Over the past 5 years, Macrogenics' Shares Outstanding (Weighted Average) peaked at $63.2 million during Q3 2025, and registered a low of $57.2 million during Q1 2021.
  • Its 5-year average for Shares Outstanding (Weighted Average) is $61.6 million, with a median of $61.9 million in 2023.
  • Per our database at Business Quant, Macrogenics' Shares Outstanding (Weighted Average) skyrocketed by 2009.23% in 2021 and then surged by 47.42% in 2022.
  • Over the past 5 years, Macrogenics' Shares Outstanding (Weighted Average) (Quarter) stood at $59.9 million in 2021, then grew by 2.48% to $61.4 million in 2022, then grew by 0.81% to $61.9 million in 2023, then grew by 1.12% to $62.6 million in 2024, then rose by 0.98% to $63.2 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $63.2 million in Q3 2025, compared to $63.1 million in Q2 2025 and $63.0 million in Q1 2025.